US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist
  • 44.000
  • -1.110-2.46%
Trading Nov 29 10:45 ET
3.39BMarket Cap-7407P/E (TTM)

About PTC Therapeutics Company

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Company Profile

SymbolPTCT
Company NamePTC Therapeutics
Listing DateJun 20, 2013
Issue Price15.00
Founded1998
CEODr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
MarketNASDAQ
Employees995
Fiscal Year Ends12-31
Address500 Warren Corporate Center Drive
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-222-7000
Websitehttp://www.ptcbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
  • Director, President and Chief Executive Officer
  • 8.94M
  • Pierre Gravier
  • Chief Financial Officer
  • 2.73M
  • Christine Utter
  • Senior Vice President, Chief Accounting Officer and Head, People Services
  • --
  • Mark E. Boulding
  • Executive Vice President and Chief Legal Officer
  • 2.19M
  • Dr. Lee Golden, M.D.
  • Executive Vice President and Chief Medical Officer
  • 2.39M
  • Eric Pauwels
  • Chief Business Officer
  • 2.41M
  • Neil Alead
  • Chief Technical Operations Officer
  • --
  • Michael Schmertzler
  • Chairman of the Board
  • 816.96K
  • Stephanie S. Okey, M.S.
  • Independent Director
  • 421.98K
  • Emma Reeve
  • Independent Director
  • 441.98K
  • Dr. Jerome Bernard Zeldis, M.D.,PhD
  • Independent Director
  • 421.98K
  • Dr. Glenn D. Steele, M.D., Ph.D.
  • Independent Director
  • 426.98K
  • William F. Bell, Jr
  • Independent Director
  • 688.36K
  • Alethia Young
  • Independent Director
  • 428.98K
  • David P. Southwell
  • Independent Director
  • 438.98K
  • Dr. Allan Jacobson, PhD
  • Independent Director
  • 511.98K
  • Mary Smith
  • Independent Director
  • 438.98K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data